Found 5 matching trials
Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian
PHASE1This is single center, open-label phase 1 dose escalation trial that uses m...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center
Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
PHASE1The purpose of this study is to test the safety of using T lymphocyte chime...
Location
Lineberger Comprehensive Cancer Center
Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells
PHASE1The purpose of this study is to test the safety and tolerability of using a...
Location
Lineberger Comprehensive Cancer Center
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
PHASE1This phase 1, single-center, open-label study explores the safety of escala...
Location
University of North Carolina
Autologous CAR-T Cells Targeting B7-H3 in PDAC
PHASE1The purpose of this gene therapy research study is to test the safety and t...
Location
University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center